Rachel Margolis-Goodman: Every Contribution Matters. Together, We Research Cures
Rachel Margolis-Goodman, Director of Advancement for the Versiti Blood Research Institute, shared on LinkedIn:
”It is hard to believe after a wonderful week with family and some online shopping, Giving Tuesday is here!
This past year, I decided to completely change my career and entered the fundraising world, and I am so grateful I did.
So on this giving Tuesday, perhaps you could consider giving back to the Versiti Blood Research Institute or Versiti on King!
Both the VBRI and Versiti on King is transforming blood health together!
From breakthrough research in our labs to trusted partnerships in our communities, Versiti is driving change at every level.
At Versiti Blood Research Institute, scientists are researching cures every day with the hope to eradicate blood disease.
At the VBRI we are driving breakthroughs in blood health, from stem cell biology to immunology.
This cutting edge research saves lives and will help shape the future of medicine.
Through Versiti on King (VOK), we’re connecting neighbors to resources, hosting blood typing events, community education events, and partnering with communities to improve health equity.
Through our programs this year, 170 people discovered they carry Ro-positive blood, the safest type for patients with sickle cell disease.
If you are unable to donate financially, please consider scheduling a blood donation today to help save up to 3 lives!
Every contribution matters. Together, we research cures.
Make your Giving Tuesday gift:
Stay updated on the emerging with Hemostasis Today.
-
Apr 23, 2026, 13:52Joffrey Feriel: A Revised ISTH Definition of Disseminated Intravascular Coagulation
-
Apr 23, 2026, 13:39Mazou Ngou Temgoua: Cancer and VTE – Toward Truly Personalized Anticoagulation
-
Apr 23, 2026, 13:35Jecko Thachil: Risk Assessment and Clinical Management of Nephrotic Syndrome–Associated Thrombosis
-
Apr 23, 2026, 12:18Mona Ranade: A Contemporary Framework for Managing Right Heart Thrombus in PE
-
Apr 23, 2026, 11:59Strengthening Hemophilia Care Through Collaboration and Commitment in India at IHC X 2026 – Hemophilia Federation India
-
Apr 23, 2026, 08:16David Ferreira: Identifying the True Drivers of Recurrent Thrombosis
-
Apr 23, 2026, 08:05Hugo Antonio Romo Rubio: Biology, Function, and Updated Classification of von Willebrand Disease
-
Apr 23, 2026, 07:50Hassan Raza: A Smarter Risk Prediction in MPNs Using AI
-
Apr 23, 2026, 05:32Why TXA and rFVIIa Are Not Equivalent in Trauma Bleeding Control – RPTH Journal